Latest News
From the Journals
Remdesivir may keep unvaccinated out of the hospital: Study
From the Journals
New studies suggest Omicron infections are less severe than Delta ones
News from the FDA/CDC
FDA authorizes Pfizer antiviral pill for COVID-19
From the Journals
Convalescent plasma cuts COVID-19 hospitalizations in half: Study
From the Journals
Bamlanivimab’s effects in COVID-19 depend on antibodies
Bamlanivimab was more effective in hospitalized COVID-19 patients without endogenous neutralizing antibodies.
From the Journals
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
The article in question investigated data integrity concerns at Pfizer vaccine clinical trial sites.
Latest News
Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
“I am hearing from colleagues from Washington state to Michigan to New York that this is the worst they have seen since the beginning of the...
Latest News
COVID cases spike as questions remain about Omicron’s threat
The Omicron variant has been detected in at least 39 states and 75 countries, according to CDC director Rochelle Walensky, MD.
News
FDA approves new myasthenia gravis drug
This approval represents “an important step in providing a novel therapy option” for patients with the rare disease.
From the Journals
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
The large-scale analysis suggests the risk is low with the adenovirus vaccine and pales in comparison with that following a positive SARS-CoV-2...
Latest News
New option for flares in pustular psoriasis
Spesolimab earns Priority Review status from the FDA for treatment of flares in generalized pustular psoriasis.